168 related articles for article (PubMed ID: 32000559)
1. Satisfaction with care and adherence to treatment when using patient reported outcomes to individualize follow-up care for women with early breast cancer - a pilot randomized controlled trial.
Riis CL; Jensen PT; Bechmann T; Möller S; Coulter A; Steffensen KD
Acta Oncol; 2020 Apr; 59(4):444-452. PubMed ID: 32000559
[No Abstract] [Full Text] [Related]
2. ePRO-based individual follow-up care for women treated for early breast cancer: impact on service use and workflows.
Riis CL; Stie M; Bechmann T; Jensen PT; Coulter A; Möller S; Steffensen KD
J Cancer Surviv; 2021 Aug; 15(4):485-496. PubMed ID: 33415653
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal assessment of real-world patient adherence: a 12-month electronic patient-reported outcomes follow-up of women with early breast cancer undergoing treatment.
Gebert P; Hage AM; Blohmer JU; Roehle R; Karsten MM
Support Care Cancer; 2024 May; 32(6):344. PubMed ID: 38740611
[TBL] [Abstract][Full Text] [Related]
4. Patient-reported quality of life, unmet needs and care coordination outcomes: Moving toward targeted breast cancer survivorship care planning.
Brennan ME; Butow P; Spillane AJ; Boyle F
Asia Pac J Clin Oncol; 2016 Jun; 12(2):e323-31. PubMed ID: 25244662
[TBL] [Abstract][Full Text] [Related]
5. Systematic screening as a tool for individualized rehabilitation following primary breast cancer treatment: study protocol for the ReScreen randomized controlled trial.
Olsson Möller U; Rydén L; Malmström M
BMC Cancer; 2020 May; 20(1):484. PubMed ID: 32471390
[TBL] [Abstract][Full Text] [Related]
6. Adherence to quality breast cancer survivorship care in four Canadian provinces: a CanIMPACT retrospective cohort study.
McBride ML; Groome PA; Decker K; Kendell C; Jiang L; Whitehead M; Li D; Grunfeld E;
BMC Cancer; 2019 Jul; 19(1):659. PubMed ID: 31272420
[TBL] [Abstract][Full Text] [Related]
7. Long-term effectiveness of an E-based survivorship care plan for breast cancer survivors: A quasi-experimental study.
Fang SY; Wang YL; Lu WH; Lee KT; Kuo YL; Fetzer SJ
Patient Educ Couns; 2020 Mar; 103(3):549-555. PubMed ID: 31558323
[TBL] [Abstract][Full Text] [Related]
8. Electronic reporting of patient-reported outcomes in a fragile and comorbid population during cancer therapy - a feasibility study.
Taarnhøj GA; Lindberg H; Dohn LH; Omland LH; Hjøllund NH; Johansen C; Pappot H
Health Qual Life Outcomes; 2020 Jul; 18(1):225. PubMed ID: 32653005
[TBL] [Abstract][Full Text] [Related]
9. Home-based multidimensional survivorship programmes for breast cancer survivors.
Cheng KKF; Lim YTE; Koh ZM; Tam WWS
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011152. PubMed ID: 28836379
[TBL] [Abstract][Full Text] [Related]
10. Open access follow-up care for early breast cancer: a randomised controlled quality of life analysis.
Kirshbaum MN; Dent J; Stephenson J; Topping AE; Allinson V; McCoy M; Brayford S
Eur J Cancer Care (Engl); 2017 Jul; 26(4):. PubMed ID: 27717057
[TBL] [Abstract][Full Text] [Related]
11. 'Re-engage' pilot study protocol: a nurse-led eHealth intervention to re-engage, educate and empower childhood cancer survivors.
Signorelli C; Wakefield CE; Johnston KA; Fardell JE; Brierley ME; Thornton-Benko E; Foreman T; Webber K; Wallace WH; Cohn RJ
BMJ Open; 2018 Apr; 8(4):e022269. PubMed ID: 29654052
[TBL] [Abstract][Full Text] [Related]
12. Protocol of a randomized controlled trial of the fear of recurrence therapy (FORT) intervention for women with breast or gynecological cancer.
Maheu C; Lebel S; Courbasson C; Lefebvre M; Singh M; Bernstein LJ; Muraca L; Benea A; Jolicoeur L; Harris C; Ramanakumar AV; Ferguson S; Sidani S
BMC Cancer; 2016 Apr; 16():291. PubMed ID: 27112319
[TBL] [Abstract][Full Text] [Related]
13. Use of a web-based app to improve breast cancer symptom management and adherence for aromatase inhibitors: a randomized controlled feasibility trial.
Graetz I; McKillop CN; Stepanski E; Vidal GA; Anderson JN; Schwartzberg LS
J Cancer Surviv; 2018 Aug; 12(4):431-440. PubMed ID: 29492753
[TBL] [Abstract][Full Text] [Related]
14. Impact of web application support versus standard management on adherence with adjuvant hormone therapy in patients treated for breast cancer: the WEBAPPAC study.
Gernier F; Grellard JM; Dupont C; Castel H; Fernette M; Lahaye F; Charles RM; Leroux T; Ory C; Faveyrial A; Morel A; Emile G; Levy C; Segura C; Allouache D; Johnson A; Geffrelot J; Gunzer K; Lelaidier A; Girault G; Dubot-Poitelon C; San C; Lequesne J; Clarisse B
BMC Cancer; 2023 Aug; 23(1):736. PubMed ID: 37559004
[TBL] [Abstract][Full Text] [Related]
15. The Women's Health Initiative cancer survivorship clinic incorporating electronic patient-reported outcomes: a study protocol for the Linking You to Support and Advice (LYSA) randomized controlled trial.
Kearns N; Raigal-Aran L; O'Connell K; Davis A; Bermingham K; O'Reilly S; Collins DC; Corrigan M; Coulter J; Cleary V; Cushen S; Flavin A; Byrne F; O'Grady A; O'Neill D; Murphy A; Dahly D; Palmer B; Connolly RM; Hegarty J
Pilot Feasibility Stud; 2022 Nov; 8(1):238. PubMed ID: 36357934
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care.
Grunfeld E; Levine MN; Julian JA; Coyle D; Szechtman B; Mirsky D; Verma S; Dent S; Sawka C; Pritchard KI; Ginsburg D; Wood M; Whelan T
J Clin Oncol; 2006 Feb; 24(6):848-55. PubMed ID: 16418496
[TBL] [Abstract][Full Text] [Related]
17. ENdometrial cancer SURvivors' follow-up carE (ENSURE): Less is more? Evaluating patient satisfaction and cost-effectiveness of a reduced follow-up schedule: study protocol of a randomized controlled trial.
Ezendam NPM; de Rooij BH; Kruitwagen RFPM; Creutzberg CL; van Loon I; Boll D; Vos MC; van de Poll-Franse LV
Trials; 2018 Apr; 19(1):227. PubMed ID: 29661218
[TBL] [Abstract][Full Text] [Related]
18. Patient-reported outcomes in survivors of breast cancer one, three, and five years post-diagnosis: a cancer registry-based feasibility study.
Skandarajah AR; Lisy K; Ward A; Bishop J; Lacey K; Mann B; Jefford M
Qual Life Res; 2021 Feb; 30(2):385-394. PubMed ID: 32997334
[TBL] [Abstract][Full Text] [Related]
19. Impact of routine assessment of health-related quality of life coupled with therapeutic information on compliance with endocrine therapy in patients with non-metastatic breast cancer: protocol for a randomized controlled trial.
Mamguem Kamga A; Di Martino C; Anota A; Paget-Bailly S; Coutant C; Arveux P; Desmoulins I; Dabakuyo-Yonli TS
Trials; 2020 Jun; 21(1):527. PubMed ID: 32546198
[TBL] [Abstract][Full Text] [Related]
20. Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis.
Ferreira AR; Di Meglio A; Pistilli B; Gbenou AS; El-Mouhebb M; Dauchy S; Charles C; Joly F; Everhard S; Lambertini M; Coutant C; Cottu P; Lerebours F; Petit T; Dalenc F; Rouanet P; Arnaud A; Martin A; Berille J; Ganz PA; Partridge AH; Delaloge S; Michiels S; Andre F; Vaz-Luis I
Ann Oncol; 2019 Nov; 30(11):1784-1795. PubMed ID: 31591636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
